|
|
1.
|
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. MedStar authors:
Year: 2017
Citation: - Cancer. 123(23):4640-4647, 2017 Dec 01
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Chawla SP, Kaiser PE, Milhem MM, Portnoy DC, Priebat DA, Samuels BL, Skubitz KM, Somaiah N, Staddon AP, Stepanski EJ, Walker MS
|
|
|
2.
|
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors:
Year: 2020
Citation: - Clinical Cancer Research. 26(6):1258-1266, 2020 03 15.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA
|
